Sauver une vie
The name Sauvie has been derived from a French sentence, “sauver une vie” which means “to save a life.” Sauvie was formed to embody this meaning in what we do with a vision to save lives by curing the diseases we treat.
We aim to harness our scientific and commercialization know-how in the field of immuno-oncology to acquire, develop and deliver critical cancer therapies globally.
Our priorities are:
Drive near-term value with BiKE
Enhance pipeline via R&D and Acquisitions
Build a sustainable business through partnerships
Well structured and positioned to attract top bio-pharma talent.
Sauvie Inc. is an emerging global biopharma company executing a diversified risk, high growth strategy.
Capabilities and experience in place to build a diversified oncology portfolio.
Development and commercialization focus to effectively bring critical medicines to patients.
Multiple shots on goal approach with high potential assets.